Our research group works towards a better understanding of the underlying biological and environmental causes of neuropsychiatric disorders and their treatment. The studies conducted by the unit combine epidemiological (general population-based) and clinical (hospital-based) research methods. In collaboration with researchers from the University of Montpellier and the Institute of Psychiatry, London, we undertake research in dementia, sleep disorders, depression, suicidal behaviour, anxiety disorder, post-traumatic stress disorder and evaluation of mental health care. The group, which today includes over 50 researchers and technical staff, is based at La Colombière Psychiatric Hospital in Montpellier. The research staff includes statutory INSERM research fellows and directors, and clinicians from the university departments of Psychiatry, Neurology and Biochemistry. In 2007 the unit became a European Associated Laboratory in association with the Department of Epidemiology, Institute of Psychiatry, King’s College, London.

  • In the next ten years there will be a 100% increase in the number of persons with Alzheimer's disease in Europe, and a 300% increase in persons of Asian origin.

  • * Of the ten most burdensome diseases in the world in 2020, five will be psychiatric disorders – with depression the number one disease world-wide for women.

  • COGNITO is a computerized neuropsychometric examination based on well-established cognitive tests for PC on a Windows operating system.